D
Debra A. Goff
Researcher at The Ohio State University Wexner Medical Center
Publications - 126
Citations - 7034
Debra A. Goff is an academic researcher from The Ohio State University Wexner Medical Center. The author has contributed to research in topics: Antimicrobial stewardship & Stewardship. The author has an hindex of 34, co-authored 116 publications receiving 4953 citations. Previous affiliations of Debra A. Goff include Ohio State University & University of Illinois at Chicago.
Papers
More filters
Journal ArticleDOI
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Evelina Tacconelli,Elena Carrara,Alessia Savoldi,Stéphan Juergen Harbarth,Marc Mendelson,Dominique L Monnet,Céline Pulcini,Gunnar Kahlmeter,Jan Kluytmans,Yehuda Carmeli,Marc Ouellette,Kevin Outterson,Jean B. Patel,Marco Cavaleri,Edward Cox,Christopher R. Houchens,M Lindsay Grayson,Paul Hansen,Nalini Singh,Ursula Theuretzbacher,Nicola Magrini,Aaron O. Aboderin,Seif Al-Abri,Nordiah Awang Jalil,Nur Benzonana,Sanjay Bhattacharya,Adrian Brink,Francesco Robert Burkert,Otto Cars,Giuseppe Cornaglia,Oliver J. Dyar,Alexander W. Friedrich,Ana Cristina Gales,Sumanth Gandra,Christian G. Giske,Debra A. Goff,Herman Goossens,Thomas Gottlieb,Manuel Guzman Blanco,Waleria Hryniewicz,Deepthi Kattula,Timothy Jinks,Souha S. Kanj,Lawrence Kerr,Marie-Paule Kieny,Yang Soo Kim,Roman S. Kozlov,Jaime Labarca,Ramanan Laxminarayan,Karin Leder,Leonard Leibovici,Gabriel Levy-Hara,Jasper Littman,Surbhi Malhotra-Kumar,Vikas Manchanda,Lorenzo Moja,Babacar Ndoye,Angelo Pan,David L. Paterson,Mical Paul,Haibo Qiu,Pilar Ramon-Pardo,Jesús Rodríguez-Baño,Maurizio Sanguinetti,Sharmila Sengupta,Mike Sharland,Massinissa Si-Mehand,Lynn L. Silver,Wonkeung Song,Martin Steinbakk,Jens Thomsen,Guy E. Thwaites,Jos W. M. van der Meer,Nguyen Van Kinh,Silvio Vega,Maria Virginia Villegas,Agnes Wechsler-Fördös,Heiman F. L. Wertheim,Evelyn Wesangula,Neil Woodford,Fidan O Yilmaz,Anna Zorzet +81 more
TL;DR: Future development strategies should focus on antibiotics that are active against multidrug-resistant tuberculosis and Gram-negative bacteria, and include antibiotic-resistant bacteria responsible for community-acquired infections.
Journal ArticleDOI
An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia.
Karri A. Bauer,Jessica E. West,Joan-Miquel Balada-Llasat,Preeti Pancholi,Kurt B. Stevenson,Debra A. Goff +5 more
TL;DR: In this article, the authors evaluated clinical and economic outcomes of a rapid polymerase chain reaction methicillin-resistant S. aureus/S. bacteremia blood culture test.
Journal ArticleDOI
Review of Rapid Diagnostic Tests Used by Antimicrobial Stewardship Programs
TL;DR: This review focuses on currently available rapid diagnostic tests and, importantly, the impact of rapid testing in combination with antimicrobial stewardship on patient outcomes.
Journal ArticleDOI
A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail
Debra A. Goff,Ravina Kullar,Ellie J. C. Goldstein,Mark Gilchrist,Dilip Nathwani,Allen C. Cheng,Kelly A. Cairns,Kevin Escandón-Vargas,Maria Virginia Villegas,Adrian Brink,Dena van den Bergh,Marc Mendelson +11 more
TL;DR: It is recommended that antibiotic stewardship models need to evolve from infection specialist-based teams to develop and use cadres of health-care professionals, including pharmacists, nurses, and community health workers, to meet the needs of the global population.
Journal ArticleDOI
Antimicrobial stewardship across 47 South African hospitals: an implementation study
Adrian Brink,Angeliki P Messina,Charles Feldman,Guy A. Richards,Piet J. Becker,Debra A. Goff,Karri A. Bauer,Dilip Nathwani,Dena van den Bergh +8 more
TL;DR: The antimicrobial stewardship programme led to a reduction in mean antibiotic defined daily doses per 100 patient-days from 101·38 in the pre-implementation phase to 83·04 in the post-im implementation phase (p<0·0001), and health-care facilities with limited infectious diseases expertise can achieve substantial returns through pharmacist-led antimacterial stewardship programmes and by focusing on basic interventions.